Company Expands Coagulation Testing Product Line

A coagulation testing product line will be expanded beyond physician offices and outpatient clinics with the development of a full line of coagulation analyzers for hospital and reference laboratories. The new line is expected to be introduced in the US and Canada in 2014, subject to regulatory approval and other requirements.

Roche Diagnostics (Indianapolis, IN, USA), a market leader in coagulation testing at the point of care, offers the CoaguChek line of handheld meters for use by healthcare professionals and patients. The new line of analyzers for the central coagulation lab, which will be marketed under Roche's cobas brand, is expected to include three platforms that address a range of customer needs, from low-volume testing to the high-throughput demands of commercial laboratories, with a complete menu of coagulation assays.

Introduction of the new lab coagulation-product line will represent a significant move into a new market for Roche in the United States and Canada.

Laboratory coagulation is estimated to be the fifth largest market in professional diagnostics worldwide, representing approximately US$1.3 billion in sales in 2010 and having a projected annual growth rate of 5.1% over the next five years.

Related Links:
Roche Diagnostics